BARCLAYS PLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 58 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$0
-100.0%
201
-98.9%
0.00%
Q2 2020$13,000
-38.1%
17,874
-14.3%
0.00%
Q1 2020$21,000
-78.6%
20,862
-66.9%
0.00%
Q4 2019$98,000
+66.1%
63,060
+93.5%
0.00%
Q3 2019$59,000
-9.2%
32,587
-18.3%
0.00%
Q2 2019$65,000
-90.3%
39,903
-89.4%
0.00%
Q1 2019$671,000
+41.6%
375,016
+49.4%
0.00%
Q4 2018$474,000
+5825.0%
251,004
+6322.8%
0.00%
Q2 2018$8,0003,9080.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$68,731,00039.63%
CVI Holdings, LLC 1,367,430$2,244,0000.87%
ESSEX INVESTMENT MANAGEMENT CO LLC 875,098$1,435,0000.20%
BARD ASSOCIATES INC 87,884$144,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 545,000$894,0000.05%
HighTower Advisors, LLC 5,284,738$8,667,0000.05%
Kore Private Wealth LLC 104,366$171,0000.04%
Arcus Capital Partners, LLC 25,000$41,0000.02%
MOORE CAPITAL MANAGEMENT, LP 320,000$525,0000.01%
MATRIX ASSET ADVISORS INC/NY 26,500$43,0000.01%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders